The pharmacokinetics of tobramycin as a single intravenous dose (3 mg/kg) were determined in young (2–3 months) and aged (22–24 months) rats and in similar groups 24 h after a single intraperitoneal injection of endotoxin (5 mg/kg). In aged rats the systemic clearance of tobramycin was significantly lower than in young rats. Endotoxin significantly decreased tobramycin clearances in both age groups, the effect being more pronounced in aged rats. The endogenous creatinine clearance followed a similar pattern as the tobramycin clearance. The volume of distribution at steady state (Vdss) was significantly lower in aged rats than in young rats. Endotoxin tended to increase Vdss in both age groups. In aged rats, however, Vdss was still significantly lower than values from young rats. The mean residence time (MRT) and terminal half-life (t½β) of tobramycin were similar in young and aged rats. Endotoxin had no effect on these parameters in young rats when compared with their controls. In aged rats, however, endotoxin significantly prolonged both MRT and t½β when compared with normal aged rats and with young endotoxin-treated rats.

Keywords:
Endotoxin, Tobramycin, Pharmacokinetics, Aged rats
This content is only available via PDF.
© 1993 S. Karger AG, Basel
1993
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.